Market Trends of Europe Autoimmune Disease Diagnostics Industry
This section covers the major market trends shaping the Europe Autoimmune Disease Diagnostics Market according to our research experts:
Rheumatoid Arthritis is Expected to Dominate the Systemic Autoimmune Disease Segment in the Coming Future
Rheumatoid arthritis is a chronic, progressive, and inflammatory autoimmune disease associated with HLA-DR4 and HLA-DR1 serotypes, characterized by persistent inflammation of the synovium that leads to the destruction of joints. The availability of treatment options, such as biologics, increasing awareness about rheumatoid arthritis, and the presence of reimbursement schemes across many countries are driving the growth of the segment. Rheumatoid arthritis (RA) is more prevalent in females. For instance, the United Kingdom has a prevalence rate of 1.2% in females and 0.4% in males.
Increasing incidence of autoimmune diseases, off-label prescription of NSAIDs, and other pain management drugs are expected to increase the demand for RA diagnosis. In addition, extensive focus on the high specificity and sensitivity of RA kits from kit manufacturers, and favorable regulatory guidelines for rapid RA diagnostic kits are expected to fuel the market growth.